# Quantitative US for Evaluation of Hepatic Steatosis in NAFLD

> **NCT04462562** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 173 (actual)

## Conditions studied

- Fatty Liver
- Fatty Liver, Nonalcoholic

## Interventions

- **DIAGNOSTIC_TEST:** Quantitative US (Samsung Medison, RS85A)

## Key facts

- **NCT ID:** NCT04462562
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-03
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-06-29
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2022-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462562, "Quantitative US for Evaluation of Hepatic Steatosis in NAFLD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04462562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*